Indaptus Therapeutics Inc [NASDAQ: INDP] closed the trading session at $0.40.
The stocks have a year to date performance of -52.50 percent and weekly performance of 5.26 percent. The stock has been moved at -60.00 percent over the last six months. The stock has performed -14.89 percent around the most recent 30 days and changed -49.09 percent over the most recent 3-months.
If compared to the average trading volume of 446.62K shares, INDP reached to a volume of 11780727 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Indaptus Therapeutics Inc [INDP]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for INDP shares is $2.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on INDP stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for Indaptus Therapeutics Inc is set at 0.05 The Price to Book ratio for the last quarter was 2.29, with the Price to Cash per share for the same quarter was set at 0.24.
INDP stock trade performance evaluation
Indaptus Therapeutics Inc [INDP] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 5.26. With this latest performance, INDP shares dropped by -14.89% in over the last four-week period, additionally sinking by -60.00% over the last 6 months – not to mention a drop of -82.91% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for INDP stock in for the last two-week period is set at 45.46, with the RSI for the last a single of trading hit 50.47, and the three-weeks RSI is set at 42.27 for Indaptus Therapeutics Inc [INDP]. The present Moving Average for the last 50 days of trading for this stock 0.4864, while it was recorded at 0.3585 for the last single week of trading, and 0.9646 for the last 200 days.
Indaptus Therapeutics Inc [INDP]: An insightful look at the core fundamentals
Indaptus Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.90 and a Current Ratio set at 1.90.
Earnings per share (EPS) analysis for Indaptus Therapeutics Inc [INDP] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for INDP. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Indaptus Therapeutics Inc go to 18.55%.
Indaptus Therapeutics Inc [INDP]: Institutional Ownership
The top three institutional holders of INDP stocks are: VANGUARD GROUP INC with ownership of 0.26 million shares, which is approximately 3.0355%. INVESTMENT HOUSE LLC, holding 0.1 million shares of the stock with an approximate value of $$0.22 million in INDP stocks shares; and INVESTMENT HOUSE LLC, currently with $$0.13 million in INDP stock with ownership which is approximately 0.7025%.
